PDGFRA and neoplasm: It has also been reported that genetic alterations, such as loss or mutations in the phosphate and tensin homologue (PTEN) gene or overexpression of the platelet-derived growth factor receptor alpha (PDGFRA) gene, represent additional molecular biomarkers that may be correlated with tumor evolution and poor prognosis (11, 12).